- The guidance was updated due to significant advances in clinical trials, particularly in the area of noninvasive testing for MASLD.
- The guideline aims to educate clinicians on the application of noninvasive testing in clinical practice. This includes how to use these tests to risk-stratify patients with MASLD and identify those at risk of progressing to cirrhosis and its complications.
- A key goal of the guideline is to help clinicians identify patients who are most at risk of serious disease progression. These patients require more focused medical attention and intervention.
- The guidance has significant implications for gastroenterology practice, particularly in improving the management and treatment of patients with MASLD.
New AASLD Practice Guidance on MASLD (GI & Endoscopy News)
0